Peran Imunitas Mukosa terhadap Infeksi Mycobacterium Tuberculosis

Irmi Syafa’ah, Resti Yudhawati

Abstract views = 499 times | downloads = 11595 times


Tuberculosis (TB) is one of major health problems in the world, with high morbidity and mortality rates. According to Global Tuberculosis Report 2015, Indonesia ranks as country with the 2nd highest number of TB cases in the world. Airway was described as a ‘gateway’ to the main pathogens, allergens and particles from the external environment. It has surveillance function that filtering beneficial and non-beneficial antigens, including Mycobacterium tuberculosis (MTB) as the causative agent of TB. MTB is a mucosal transmitted pathogen, infects human through mucosal tissue of respiratory tract. Airway mucosa was considered as the first barrier as well as inductive sites to initiate mucosal immune response against MTB. In this literature, the role of mucosal immune system, in this case especially airway mucosa, and its role against Mycobacterium tuberculosis infection in humans will be further discussed.


Bronchiectasis, Lung TB, Airway mucosa, Immune response

Full Text:



Global Tuberculosis Report 2014. World Health Organization, 2014.

Williams A, Hussell T, Lloyd C. Immunology: mucosal and body surface defences. Chichester, West Sussex ; Hoboken, NJ: WileyBlackwell; 2012. xvii, 380 p.

Li W, Deng G, Li M, Liu X, Wang Y. Roles of Mucosal Immunity against Mycobacterium tuberculosis Infection. Tuberculosis research and treatment. 2012;2012:791728.

Tjärnlund A. Does IgA play a role in protection against pulmonary tuberculosis? Sweden: Stockholm University; 2005.

Abebe F, Bjune G. The protective role of antibody responses during Mycobacterium tuberculosis infection. Clinical and experimental immunology. 2009;157(2):235–43.

Mayer AK, Dalpke AH. Regulation of local immunity by airway epithelial cells. Archivum immunologiae et therapiae experimentalis. 2007;55(6):353–62.

Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA. Mucins in the mucosal barrier to infection. Mucosal immunology. 2008;1(3):183–97.

Lillehoj ER, Kim KC. Airway mucus: its components and function. Archives of pharmacal research. 2002;25(6):770–80.

Schutte BC, McCray PB, Jr. [beta]-defensins in lung host defense. Annual review of physiology. 2002;64:709–48.

Flynn JL. Immunology of tuberculosis and implications in vaccine development. Tuberculosis. 2004;84(1-2):93–101.

Li Y, Wang Y, Liu X. The role of airway epithelial cells in response to mycobacteria infection. Clinical & developmental immunology. 2012;2012:791392.

de Larrea CF, de Waard JH, Giampietro F, Araujo Z. The secretory immunoglobulin A response to Mycobacterium tuberculosis in a childhood population. Revista da Sociedade Brasileira de Medicina Tropical. 2006;39(5):456–61.

Sato S, Kiyono H. The mucosal immune system of the respiratory tract. Current opinion in virology. 2012;2(3):225–32.

Urdahl KB, Shafiani S, Ernst JD. Initiation and regulation of T-cell responses in tuberculosis. Mucosal immunology. 2011;4(3):288– 93.

Dheda K, Schwander SK, Zhu B, van Zyl-Smit RN, Zhang Y. The immunology of tuberculosis: from bench to bedside. Respirology. 2010;15(3):433–50.

Kolls JK, Khader SA. The role of Th17 cytokines in primary mucosal immunity. Cytokine & growth factor reviews. 2010;21(6):443–8.

Chen X, Zhou B, Li M, Deng Q, Wu X, Le X, et al. CD4(+)CD25(+) FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clinical immunology (Orlando, Fla). 2007;123(1):50–9.

Mihret A. The role of dendritic cells in Mycobacterium tuberculosis infection. Virulence. 2012;3(7):654–9.

Weiss G, Schaible UE. Macrophage defense mechanisms against intracellular bacteria. Immunological reviews. 2015;264:182–203.

Cavalcanti YV, Brelaz MC, Neves JK, Ferraz JC, Pereira VR. Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis. Pulmonary medicine. 2012;2012:745483.

Cooper AM, Mayer-Barber KD, Sher A. Role of innate cytokines in mycobacterial infection. Mucosal immunology. 2011;4(3):252–60.

Dietrich J, Andersen C, Rappuoli R, Doherty TM, Jensen CG, Andersen P. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity. Journal of immunology (Baltimore, Md: 1950). 2006;177(9):6353–60.

Reljic R, Sibley L, Huang JM, Pepponi I, Hoppe A, Hong HA, et al. Mucosal vaccination against tuberculosis using inert bioparticles. Infect Immune. 2013;81(11):4071–80.


  • There are currently no refbacks.

View My Stats



Creative Commons License

JR (p-ISSN: 2407-0831e-ISSN: 2621-8372) is licensed under Creative Commons Attribution-ShareAlike 4.0 International License.